Insider · CIK 0001352447

St Peter Steven

CIK 0001352447 Name as filed on the most recent filing

Filed as St Peter Steven (35)

47 transaction lines · from 35 filings · filed 2007-01-05 to 2018-12-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

22 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-12-17 S, Open-market sale Aratana Therapeutics, Inc.PETX 269,788, disposed Open Form 4 filing 0001209191-18-063022
2018-10-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 67,454, disposed Open Form 4 filing 0001209191-18-056699
2018-09-21 S, Open-market sale Aratana Therapeutics, Inc.PETX 454,305, disposed Open Form 4 filing 0001209191-18-051980
2018-07-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 49,842, disposed Open Form 4 filing 0001209191-18-044452
2018-04-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 57,582, disposed Open Form 4 filing 0001209191-18-027217
2018-04-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 57,582, acquired Open Form 4 filing 0001209191-18-026909
2018-01-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 92,301, disposed Open Form 4 filing 0001209191-18-006531
2017-11-10 S, Open-market sale Aratana Therapeutics, Inc.PETX 350,000, disposed Open Form 4 filing 0001209191-17-060431
2017-10-02 S, Open-market sale Aratana Therapeutics, Inc.PETX 312,115, disposed Open Form 4 filing 0001209191-17-055949
2017-04-17 S, Open-market sale Aratana Therapeutics, Inc.PETX 277,150, disposed Open Form 4 filing 0001209191-17-027348
2017-01-27 S, Open-market sale Aratana Therapeutics, Inc.PETX 385,875, disposed Open Form 4 filing 0001209191-17-006464
2016-12-15 S, Open-market sale Aratana Therapeutics, Inc.PETX 381,380, disposed Open Form 4 filing 0001209191-16-155708
2016-08-09 S, Open-market sale Aratana Therapeutics, Inc.PETX 462,500, disposed Open Form 4 filing 0001209191-16-136411
2016-06-17 S, Open-market sale Aratana Therapeutics, Inc.PETX 158,020, disposed Open Form 4 filing 0001209191-16-128718
2016-06-16 S, Open-market sale Aratana Therapeutics, Inc.PETX 468,293, disposed Open Form 4 filing 0001209191-16-128718
2015-03-19 P, Open-market purchase Pharmathene, IncPIP 41,213, acquired Open Form 4 filing 0001144204-15-017845
2015-01-13 S, Open-market sale Aratana Therapeutics, Inc.PETX 1,442,408, disposed Open Form 4 filing 0001209191-15-003965
2015-01-02 S, Open-market sale Aratana Therapeutics, Inc.PETX 446,648, disposed Open Form 4 filing 0001209191-15-002318
2014-09-02 S, Open-market sale Aratana Therapeutics, Inc.PETX 291,863, disposed Open Form 4 filing 0001181431-14-031104
2014-06-02 S, Open-market sale Aratana Therapeutics, Inc.PETX 336,805, disposed Open Form 4 filing 0001181431-14-022157
2013-07-02 P, Open-market purchase Aratana Therapeutics, Inc.PETX 49,998, acquired Open Form 4 filing 0001181431-13-038919
2012-02-01 P, Open-market purchase Verastem, Inc.VSTM 1,000,000, acquired Open Form 4 filing 0001209191-12-007620
2011-11-21 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2,999,997, acquired Open Form 4 filing 0001209191-11-057585
2011-02-08 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2 lines 3,749,998, acquired Open Form 4 filing 0001209191-11-010540
2009-02-12 P, Open-market purchase Peplin IncPLIN 10,242, acquired Open Form 4 filing 0001209191-09-008572
2009-02-11 P, Open-market purchase Peplin IncPLIN 7,992, acquired Open Form 4 filing 0001209191-09-008572
2009-02-09 P, Open-market purchase Peplin IncPLIN 7,992, acquired Open Form 4 filing 0001209191-09-007923
2009-02-05 P, Open-market purchase Peplin IncPLIN 20,654, acquired Open Form 4 filing 0001209191-09-007153
2009-01-27 P, Open-market purchase Peplin IncPLIN 2 lines 13,716, acquired Open Form 4 filing 0001209191-09-005046
2009-01-23 P, Open-market purchase Peplin IncPLIN 48,232, acquired Open Form 4 filing 0001209191-09-005046
2009-01-22 P, Open-market purchase Peplin IncPLIN 2 lines 20,914, acquired Open Form 4 filing 0001209191-09-004708
2009-01-21 P, Open-market purchase Peplin IncPLIN 7,456, acquired Open Form 4 filing 0001209191-09-004708
2009-01-20 P, Open-market purchase Peplin IncPLIN 378, acquired Open Form 4 filing 0001209191-09-003975
2009-01-19 P, Open-market purchase Peplin IncPLIN 7,372, acquired Open Form 4 filing 0001209191-09-003975
2009-01-16 P, Open-market purchase Peplin IncPLIN 60,188, acquired Open Form 4 filing 0001209191-09-003975
2009-01-15 P, Open-market purchase Peplin IncPLIN 12,464, acquired Open Form 4 filing 0001209191-09-003975
2009-01-13 P, Open-market purchase Peplin IncPLIN 48,584, acquired Open Form 4 filing 0001209191-09-003416
2007-09-14 S, Open-market sale Memory Pharmaceuticals CorpMEMY 57,960, disposed Open Form 4 filing 0001209191-07-053964
2007-09-13 S, Open-market sale Memory Pharmaceuticals CorpMEMY 132,120, disposed Open Form 4 filing 0001209191-07-053453
2007-09-12 S, Open-market sale Memory Pharmaceuticals CorpMEMY 21,611, disposed Open Form 4 filing 0001209191-07-053453
2007-08-13 S, Open-market sale Omrix Biopharmaceuticals, Inc.OMRI 81,098, disposed Open Form 4 filing 0001209191-07-048013
2006-12-18 P, Open-market purchase Memory Pharmaceuticals CorpMEMY 2,569,818, acquired Open Form 4 filing 0001181431-07-002395

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 20
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. St Peter Steven, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001352447

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.